Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories
|
|
- Rose Rice
- 6 years ago
- Views:
Transcription
1 Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/14 Protecting and promoting the health and safety of the people of Wisconsin
2 Overview Lyme disease epidemiology and statistics. Laboratory testing and interpretations. Treatment and prevention. Review of reporting requirements in Wisconsin. 2
3 Lyme Disease Borrelia burgdorferi 3
4 Most Frequently Reported Notifiable Diseases in Wisconsin, 2012 Reported Cases 1. Chlamydia 23, Pertussis 6, Gonorrhea 4, Hepatitis C 2, Lyme disease 1, Influenza-associated hospitalization 1, Campylobacteriosis 1, Mycobacterial (non-tuberculous) 1, Salmonellosis Cryptosporidiosis 637 4
5 Reported Lyme Disease Cases (n=28,446) * No. of Cases Year of Illness Onset Incidence Estimated Cases Probable Cases Confirmed Cases Incidence per 100,000 *Surveillance case definition change to include probable cases Reporting criteria change Rev 01/30/
6 Lyme Disease 3-Year Average Incidence,
7 Early Localized Stage: Erythema Migrans (EM) Rash Skin lesions typically begin as a red macule or papule and expands over a period of days to weeks to form a large round lesion, often with partial central clearing. Located at site of the tick bite after 3-30 days, with an average of 11 days, in ~70% of infected persons. A rash that is 5cm (2 in) is diameter is considered diagnostic, laboratory testing is not needed. Erythematous lesions occurring within several hours of a tick bite may be the result of a hypersensitivity reaction, which would not be considered an EM rash. 7
8 Erythema Migrans (EM) Rash Source: CDC.gov 8
9 Lyme Disease: Early Disseminated Stage Occurs days to weeks after tick bite. Multiple disseminated EM rashes. Arthritis (asymmetrical, larger joints). Cranial neuritis (Bell s palsy). Radiculoneuropathy. Lymphocytic meningitis. Second and third degree atrioventricular block. Fever and chills. Headaches. Malaise or fatigue. Myalgia and arthralgia. Dizziness. Generalized lymphadenopathy. Myocarditis. Palpitations. 9
10 Lyme Disease: Late Persistent Stage Occurs months to years after tick bite. Arthritis (asymmetrical, larger joints). Encephalomyelitis. Other neurologic abnormalities. Cardiovascular abnormalities. Fatigue. Numbness in hands and feet. Cognitive impairment. 10
11 Clinical Manifestations of Confirmed Lyme Disease Cases, United Sates, Source: CDC.gov 11
12 Rev 05/09/2011 Confirmed Lyme Disease Cases Wisconsin 2012 (n=1,487) 12 Jan Feb Mar April May June July Aug Sept Oct Nov Dec Month of Illness Onset No. of Confirmed Cases Updated 01/30/2014
13 Confirmed Lyme Disease Cases Wisconsin 2012 (n=1,487) 13
14 Laboratory Testing 14
15 Lyme Disease Testing Methods Serologic assays Enzyme immunoassay (EIA) tests. Immunofluorescent assays (IFA). Western Blot test. PCR Molecular method of detecting DNA of organism (synovial fluid). Culture Detects growth of organism to confirm active infection. 15
16 Lyme Disease - Antibody Response Both IgM and IgG can persist for years. IgM response Produced earlier than IgG. Peaks within the first several weeks. Less specific than IgG. Less reliable as a marker for Lyme disease, particularly for patients with later stages of illness. 16
17 Lyme Disease - Antibody IgG Response IgG response Produced a few weeks after IgM. Peaks months to years. More specific then IgM. More reliable marker for Lyme disease. 17
18 CDC Laboratory Criteria: 2008 Case Definition Lyme Disease Two-Tiered Testing 1st tier: EIA or IFA test (sensitive but less specific) Screening test EIA result is reported as an index number IFA result is reported as a titer 2nd tier: WB test (specific but less sensitive) Results are reported out as bands IgM (2 out of 3 bands): 41, 39, kda IgG (5 out of 10 bands): 18, 21-15, 28, 30, 39, 41, 45, 58, 66, 93 kda 18
19 Source: CDC.gov 19
20 Testing Limitations A negative result during the EM phase or in a PCR test does not exclude the possibility of infection with B. burgdorferi. A positive result is not definitive evidence of current infection with B. burgdorferi, clinical signs and symptoms are needed. Other conditions including syphilis, periodontal disease, rheumatoid arthritis, and systemic lupus erythematosus can cross react with antibody tests. Antibodies can persist for years. Use testing as supportive evidence of infection. 20
21 Laboratory Tests Whose of Questionable Use Detection of antigens in urine. Detection of cell wall deficient or cystic forms of B.burgdorferi. Reverse Western blot. Lymphocyte based assays. Measurements of antibodies in synovial fluid. Certain culture and PCR techniques that have not been peer-reviewed. In-house criteria for interpreting immunoblots. 21
22 Treatment and Prevention 22
23 Lyme Disease - Treatment CDC follows the Infectious Diseases Society of America (IDSA) guidelines. Antibiotics are very effective if treated early. Recurrent symptoms may require a additional courses of antibiotics. Long-term intravenous courses (months to years) have not been shown to be beneficial and may cause more complications. Cholecystitis and gallstones, catheter-associated bloodstream infections, fatal Clostidium difficile infection. 23
24 Lyme Disease - Treatment 2009 Red Book, 28 th edition, pages The Clinical Assessment, Treatment and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Wormser GP et al CID 2006;43:
25 Recommended Treatment Early localized disease Age > 8 years Age <8 years or unable to tolerate doxycycline Doxycycline* 100 mg PO BID for days Amoxicillin 50 mg/kg/d PO divided into 3 doses (maximum 1.5 g/d) for days -OR- Cefuroxime 30 mg/kg/d PO in 2 divided doses (maximum 1.0 g/d) for days *Tetracyclines contraindicated during pregnancy. 25
26 Recommended Treatment Early disseminated and late disease Arthritis Same PO regimen as for early localized disease but for 28 days Persistent or recurrent arthritis* Ceftriaxone sodium, mg/kg IV or IM once daily (max 2g/d) for days Penicillin 300,000 U/kg IV in divided doses q4h (max 20 m U/d) for days -OR- -OR- Same oral regimen as for early disease *Objective evidence of synovitis exists at least 2 months after treatment initiated. 26
27 Recommended Treatment Early disseminated and late disease Multiple erythema migrans Isolated facial palsy Carditis Meningitis or encephalitis Same PO regimen as for early localized disease but for 21 days Same PO regimen as for early localized disease but for days* Ceftriaxone or penicillin: see persistent or recurrent arthritis Ceftriaxone IV or penicillin IV: see persistent or recurrent arthritis *Corticosteroids should not be given. Rx has no effect on the resolution facial nerve palsy; it s purpose is to prevent late disease. 27
28 Prevention Avoid tick exposures when possible. Use tick repellents % DEET. Permethrin on clothes. No currently available vaccine. No lasting immunity. Prophylaxis. 28
29 Prophylaxis Patient is bitten by an Ixodes scapularis tick (blacklegged tick; deer tick) in Wisconsin. Was the tick attached to the patient for 24 hours? Yes Has it been 72 hours since the tick was removed from the patient? Yes No No Prophylaxis treatment is not recommended. Prophylaxis treatment is not recommended. Is doxycycline contraindicated for the patient (less than 8 years of age, pregnant, etc.)? No Yes Prophylaxis treatment is not recommended. Prophylaxis treatment is recommended. Guidelines are based on those recommended by the ISDA. Prophylaxis Treatment: A single dose of doxycycline, 4 mg/kg up to a maximum dose of 200 mg. 29
30 Ixodes scapularis ticks demonstrating changes in blood engorgement after various durations of attachment. A: Nymphal stage. B: Adult stage. The pictures are a generous gift from Dr. Richard Falco (Fordham University). 30
31 Lyme Disease Reporting 25
32 Reporting Requirements as of June 2012 Required reporting: Laboratories continue to report all Lyme positive results. Health care providers continue to report all cases of erythema migrans (EM 5 cm and diagnosed by a physician or medical personnel). Continue to report date of illness onset and patient demographic information (address, birth date, gender, race, and ethnicity). Optional reporting: Reporting of Lyme disease cases without EM rash (including non- EM confirmed and probable cases) is optional, unless requested by the local health departments. Reporting of signs and symptoms other than EM rash, exposure, and treatment information is now optional, unless requested by the LHDs. 32
33 How to Report Lyme Disease Cases Electronically via the Wisconsin Electronic Disease Surveillance System (WEDSS). Contact Division of Public Health WEDSS staff. Mail or fax the Wisconsin Lyme Disease Case Report Form to the appropriate Local Health Department or to the Division of Public Health. Forms/EpiCRFLyme.pdf Acute and Communicable Disease Case Report. Phone call to LHD or any other means of reporting. 33
34 References 1. Feder HM Jr., Johnson BJB, O Connell S, et al. A critical appraisal of chronic Lyme disease. NEJM 2007;357: (plus correction of author listing NEJM 2008;358:1084). 2. Nadelman RB, Nowakowski J, Fish D et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. NEJM 2001;345: Warshafsky S, Lee DH, Francois LK et al. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother 2010;65: Wormser GP, Dattwyler RJ, Shapiro ED et al. The Clinical Assessment, Treatment and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. CID 2006;43:
35 Resources ble/tickborne/index.htm ans.html 35
36 Additional Questions For all vectorborne questions: Diep (Zip) Hoang Johnson, Epidemiologist Phone: (608) For Lyme disease: Christopher Steward, Research Analyst Phone: (608)
Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014
Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014 Protecting and promoting the health and safety of the people of Wisconsin
More informationLYME DISEASE Last revised May 30, 2012
Wisconsin Department of Health Services Division of Public Health Communicable Disease Surveillance Guideline LYME DISEASE Last revised May 30, 2012 I. IDENTIFICATION A. CLINICAL DESCRIPTION: A multi-systemic
More informationSTATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA
INFECTIOUS DISEASES EXPERT GROUP (IDEG) DEPARTMENT OF HEALTH AND WELLNESS STATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA Executive Summary: In 2016, the Public Health Agency of Canada (PHAC) modified
More informationInfectious Diseases Expert Group (IDEG) Department of Health and Wellness. Statement for Managing Lyme Disease in Nova Scotia
Infectious Diseases Expert Group (IDEG) Department of Health and Wellness Statement for Managing Lyme Disease in Nova Scotia 2018 Executive Summary: In 2016, the Public Health Agency of Canada (PHAC) modified
More informationTick Talk: What s new in Lyme Disease. May 5 th, 2017 Cristina Baker, M.D., M.P.H.
Tick Talk: What s new in Lyme Disease May 5 th, 2017 Cristina Baker, M.D., M.P.H. Dr. Baker indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationMedical Review Criteria Lyme/Tick-Borne Diseases: Use of Parenteral Antibiotics
Medical Review Criteria Lyme/Tick-Borne Diseases: Use of Parenteral Antibiotics Subject: Lyme/Tick-Borne Diseases: Use of Parenteral Antibiotics Authorization: Prior authorization is required for ALL parenteral
More informationLyme Disease. 1. DISEASE REPORTING A. Purpose of Reporting and Surveillance
1. DISEASE REPORTING A. Purpose of Reporting and Surveillance Lyme Disease 1. To determine the incidence of Lyme disease, the degree of endemicity, and potential risk of contracting Lyme disease in Washington
More informationLyme Disease, an Infectious Diseases Perspective
Lyme Disease, an Infectious Diseases Perspective Lyme: Pretest 1. The pathognomonic finding of Lyme disease is: 1. An indurated lesion, measuring ~ 2 cm in diameter with a central, necrotic eschar. 2.
More informationCorporate Medical Policy
Corporate Medical Policy Intravenous Antibiotic Therapy for Lyme Disease File Name: intravenous_antibiotic_therapy_for_lyme_disease Origination: 3/2006 Last CAP Review: 2/2017 Next CAP Review: 2/2018 Last
More informationTHIS IS AN OFFICIAL NH HEALTH ALERT
THIS IS AN OFFICIAL NH HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@dhhs.nh.gov June 01, 2017, 1100 EDT (11:00 AM EDT) NH-HAN 20170601 Emerging Tickborne Diseases in New Hampshire
More informationSeroprevalence of Babesia microti in Individuals with Lyme Disease. Sabino R. Curcio, M.S, MLS(ASCP)
Seroprevalence of Babesia microti in Individuals with Lyme Disease Sabino R. Curcio, M.S, MLS(ASCP) Lyme Disease Most common vectorborne illness in the United States Caused by the tick-transmitted spirochete
More informationLyme Disease. (Borrelia burgdorferi) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS
Lyme Disease (Borrelia burgdorferi) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per NJAC 8:57, health care providers and administrators shall report by mail or by electronic reporting within 24 hours
More informationPeter J. Weina, PhD, MD, FACP, FIDSA. Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research
Peter J. Weina, PhD, MD, FACP, FIDSA Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research Background Most common vector-borne disease in U.S. First described in Lyme,
More informationTick-borne Infections
Tick-borne Infections Wei Li Adeline Koay, MBBS, MSc, FAAP Attending, Infectious Diseases Children s National Medical Center, Washington DC Kari Simonsen, MD, FAAP Professor and Vice Chair of Pediatrics
More informationMy Case Study Solution
My Case Study Solution By Chiara Corey Amy and John, recent newlyweds and hiking enthusiasts from California, completed a backpacking road trip across the United States for their honeymoon. They started
More informationTitle: Public Health Reporting and National Notification for Lyme Disease
10-ID-06 Committee: Infectious Disease Title: Public Health Reporting and National Notification for Lyme Disease I. tatement of the Problem: CTE position statement 07-EC-02 recognized the need to develop
More informationLyme Disease. By Farrah Jangda
Lyme Disease By Farrah Jangda Disease Name: Lyme Disease Lyme disease is a common tick-borne bacterial infection transmitted from the bite of a tick in United States and Europe (2). It is caused by the
More informationTechnical Bulletin No. 121
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 121 January 31, 2014 Lyme Blot, IgG and IgM - Now Performed at CPAL Contact: J. Matthew Groeller, 717.851.1416 Operations Manager, Clinical
More informationLyme Disease. Abstract Lyme disease is a vector borne infection primarily transmitted by Ixodes ticks and. Special Issue
Special Issue Lyme Disease Min Geol Lee, M.DYoung Hun Cho, M.D. Department of Dermatology Yonsei University College of Medicine, Severance Hospital Email : mglee@yumc.yonsei.ac.krsalute@yumc.yonsei.ac.kr
More informationTickborne Diseases: Challenges and Controversies
Tickborne Diseases: Challenges and Controversies JENNIFER HANRAHAN, D.O. ASSOCIATE PROFESSOR, CWRU DIRECTOR OF INFECTION PREVENTION METROHEALTH MEDICAL CENTER Disclosures I have been on Advisory Boards
More informationNot currently the time of year, but spring is around the corner. Seems to be in the news every other week. Task forces being formed.
1 2 3 Not currently the time of year, but spring is around the corner. Seems to be in the news every other week. Task forces being formed. Elizabeth May has been a big proponent. Avril Lavigne has come
More informationPublic Statement: Medical Policy Statement:
Medical Policy Title: Lyme Disease, Intravenous Antibiotic Therapy ARBenefits Approval: 10/19/2011 and Associated Diagnostic Testing Effective Date: 01/01/2012 Document: ARB0235 Revision Date: Code(s):
More informationAnnouncements. Please mute your phones and DO NOT place us on hold. Press *6 to mute your phone.
Announcements Register for the Epi-Tech Trainings: 1. Log-on or Request log-on ID/password: https://tiny.army.mil/r/zb8a/cme 2. Register for Epi-Tech Surveillance Training: https://tiny.army.mil/r/dvrgo/epitechfy14
More informationA More Sustainable Lyme Disease Surveillance System
A More Sustainable Lyme Disease Surveillance System Christopher Steward Wisconsin Division of Public Health Overview Lyme disease, reporting, and surveillance Changes to reporting criteria Case estimations
More informationFatigue, persistence after Lyme borreliosis 196, 197 Francisella tularensis, see Tularemia
Subject Index Acrodermatitis chronica atrophicans (ACA) antibiotic therapy 121, 122 Borrelia induction 13 clinical characteristics 64, 65, 82 diagnosis 65, 66 differential diagnosis 66 etiology 62 frequency
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Intravenous Antibiotic Therapy and Associated Page 1 of 18 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Intravenous Antibiotic Therapy and Associated Professional
More informationA Patient s Guide to Lyme Disease
A Patient s Guide to Lyme Disease 2350 Royal Boulevard Suite 200 Elgin, IL 60123 Phone: 847.931.5300 Fax: 847.931.9072 DISCLAIMER: The information in this booklet is compiled from a variety of sources.
More informationEfficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis
J Antimicrob Chemother 2010; 65: 1137 1144 doi:10.1093/jac/dkq097 Advance publication 9 April 2010 Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and
More informationNO DISCLOSURES. Lyme Disease Convention and Controversies. Willie Burgdorfer, Ph.D. ( ) RM Lab in Hamilton, MT 1/20/2017
Lyme Disease Convention and Controversies Richard A. Jacobs, M.D., PhD. NO DISCLOSURES Willie Burgdorfer, Ph.D. (1925 2014) RM Lab in Hamilton, MT Polly Murray who first reported an outbreak of arthritis
More informationTitle: A modification of the exposure criteria used as part of the case definition to help classify cases of Lyme disease.
16-ID-10 Committee: Infectious Disease Title: A modification of the exposure criteria used as part of the case definition to help classify cases of Lyme disease. I. tatement of the Problem According to
More informationLyme disease Overview
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 21 Lyme Disease Learning Objectives 1. Describe the agent and vector of Lyme Disease 2. Identify the geographic and temporal patterns
More informationLYME DISEASE. Page. Lyme Disease: Medical Policy (Effective 10/01/2013)
MEDICAL POLICY LYME DISEASE Policy Number: 2013T0351K Effective Date: October 1, 2013 Table of Contents COVERAGE RATIONALE... BENEFIT CONSIDERATIONS... BACKGROUND... CLINICAL EVIDENCE... U.S. FOOD AND
More informationLyme Disease Diagnosis and Treatment
Last Review Date: October 13, 2017 Number: MG.MM.ME.57a Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationA Patient s Guide to Lyme Disease
A Patient s Guide to Lyme Disease Suite 11-13/14/15 Mount Elizabeth Medical Center 3 Mount Elizabeth Singapore, 228510 Phone: (65) 6738 2628 Fax: (65) 6738 2629 DISCLAIMER: The information in this booklet
More informationSELECTED INFECTIONS ACQUIRED DURING TRAVELLING IN NORTH AMERICA. Lin Li, MD August, 2012
SELECTED INFECTIONS ACQUIRED DURING TRAVELLING IN NORTH AMERICA Lin Li, MD August, 2012 Case 1 32 year old male working in Arizona; on leave back in Singapore Presented to hospital A for fever x (7-10)
More informationTick-borne Disease Surveillance
Tick-borne Disease Surveillance Catherine M. Brown, DVM, MSc, MPH Deputy State Epidemiologist and State Public Health Veterinarian Department of Public Health Bureau of Infectious Disease William A. Hinton
More informationIntravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease Policy Number: 5.01.08 Last Review: 01/2018 Origination: 1/2009 Next Review: 01/2019 Policy Blue Cross and Blue Shield
More informationTickborne Disease in New Hampshire HEHNA Meeting Elliot Hospital September 27, 2017
Tickborne Disease in New Hampshire HEHNA Meeting Elliot Hospital September 27, 2017 Carolyn Fredette, MPH Vectorborne Disease Surveillance Coordinator Division of Public Health Services, DHHS Infectious
More informationLyme disease Overview
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, Dr.PH) Lecture 22 Lyme Disease Learning Objectives 1. Describe the agent and vector of Lyme Disease 2. Identify the geographic and temporal patterns
More informationAlabama Medicaid Pharmacist
Published Quarterly by Health Information Designs, LLC, Summer 2013 edition A Service of Alabama Medicaid PDL Update Effective July 1, 2013, the Alabama Medicaid Agency will update the Preferred Drug List
More informationLyme Neuroborreliosis
Lyme Neuroborreliosis Presenter: Elitza S. Theel, Ph.D., D(ABMM) Director of Infectious Diseases Serology Co-Director, Vector-Borne Diseases Service Line Department of Laboratory Medicine and Pathology
More informationLyme Disease: Prevention, Recognition & Treatment
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2017 Lyme Disease: Prevention, Recognition & Treatment Kristen J. Bartlett University of Vermont
More informationTwo Standards of Care
Two Standards of Care ILADS and IDSA guidelines reflect deeply divided opinions about treatment approaches, clinical judgment and patient preferences By Lorraine Johnson, JD, MBA Medically recognized standards
More information2/7/2018. Lyme Disease Convention and Controversies. Richard A. Jacobs, M.D., PhD. NO DISCLOSURES
Lyme Disease Convention and Controversies Richard A. Jacobs, M.D., PhD. NO DISCLOSURES 1 Willie Burgdorfer, Ph.D. (1925 2014) RM Lab in Hamilton, MT Polly Murray who first reported an outbreak of arthritis
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Feder HM Jr, Johnson BJB, O Connell S, et al. A critical appraisal
More informationLyme disease conference
Lyme disease conference Epidemiology of Lyme in England and Wales Robert Smith, Public Health Wales 9 October 213 Lyme disease in England and Wales Dr Robert Smith Health Protection Division Public Health
More informationTickborne Disease Case Investigations
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Tickborne Disease Case Investigations Anthony Osinski, MPH May 31, 2018 Factors Associated with Increasing
More informationMP Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease. Related Policies None
Medical Policy BCBSA Ref. Policy: 5.01.08 Last Review: 10/18/2018 Effective Date: 10/18/2018 Section: Prescription Drug Related Policies None DISCLAIMER Our medical policies are designed for informational
More informationThe new england journal of medicine. The Clinical Problem
The new england journal of medicine clinical practice Caren G. Solomon, M.D., M.P.H., Editor Lyme Disease Eugene D. Shapiro, M.D. This Journal feature begins with a case vignette highlighting a common
More informationPersistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi Years after Active Lyme Disease
MAJOR ARTICLE Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi 10 20 Years after Active Lyme Disease Robert A. Kalish, 1 Gail McHugh, 1 John Granquist, 1 Barry
More informationTicks & Tickborne Diseases of Minnesota. Vectorborne Diseases Unit Last Updated February 16, 2018
Ticks & Tickborne Diseases of Minnesota Vectorborne Diseases Unit Last Updated February 16, 2018 What is a tickborne disease and why should you care about it? People can get a tickborne disease when they
More informationClinical Policy Title: Lyme disease diagnosis and treatment
Clinical Policy Title: Lyme disease diagnosis and treatment Clinical Policy Number: 18.01.05 Effective Date: March 1, 2017 Initial Review Date: February 15, 2017 Most Recent Review Date: February 15, 2017
More informationTHE communicable disease Communiqué
THE communicable disease Communiqué M C H E N R Y C O U N T Y D E P A R T M E N T O F H E A L T H COMMUNICABLE DISEASE EMERGENCY NOTIFICATION INFORMATION Urgent Public Health issues shall be reported immediately
More informationPractitioners often encounter
Practical advice for treating newborns and toddlers. Making Lemonade out of Lyme Stan L. Block, MD, FAAP Practitioners often encounter peculiar round/oval rashes in pediatric patients, particularly during
More informationAcute Lyme disease is a well known and recognized infection caused by the Borrelia burgdorferi spirochete and associated tick borne organisms.
Acute Lyme disease is a well known and recognized infection caused by the Borrelia burgdorferi spirochete and associated tick borne organisms. It is endemic to much of the United States and Europe and
More informationRecognizing the Clinical and Laboratory Presentation of Human Granulocytic Anaplasmosis
Recognizing the Clinical and Laboratory Presentation of Human Granulocytic Anaplasmosis NICOLE FENNIMORE, 3 RD YEAR MEDICAL STUDENT UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH FRIDAY,
More informationAcute Genital Ulcerations
Acute Genital Ulcerations Rachel Clarke, MD Chief Resident Weijen Chang, MD FAAP SFHM Associate Professor Baystate Children s Hospital University of Massachusetts Medical School Disclosures In the past
More informationNecrotizing Granulomatous Hepatitis as an Unusual Manifestation of Lyme Disease
Dig Dis Sci (2007) 52:2629 2632 DOI 10.1007/s10620-006-9405-9 Necrotizing Granulomatous Hepatitis as an Unusual Manifestation of Lyme Disease Antonela C. Zanchi Alan R. Gingold Neil D. Theise Albert D.
More informationLyme disease is an uncommon, but not
Continuing Medical Education Lyme Disease in Women: Recognition, Treatment, and Prevention Jonathan L. Temte, MD, PhD Lyme disease is easily treated, but the elusive symptoms require a high index of suspicion
More informationMCDB 3650 Lyme Disease. Team LTD Paige Hoffman, Victoria Schelkun, Madison Purdy, Evan Gallagher
MCDB 3650 Lyme Disease Team LTD Paige Hoffman, Victoria Schelkun, Madison Purdy, Evan Gallagher Overview Review of lyme disease Current treatment options and their problems Chronic/persistent lyme disease
More informationMassachusetts face to face with Lyme disease patient protection bill
Massachusetts face to face with Lyme disease patient protection bill One of the most misunderstood and underdiagnosed diseases today is Lyme disease. Each year approximately 30,000 cases of Lyme disease
More informationThe Federal Tick-borne Disease Working Group and CDC's current activities on IPM for Lyme disease prevention and control
The Federal Tick-borne Disease Working Group and CDC's current activities on IPM for Lyme disease prevention and control C. Ben Beard, Ph.D. Chief, Bacterial Diseases Branch CDC Division of Vector-Borne
More informationNO DISCLOSURES. Lyme Disease. Outline. Case. Case. Case 2/10/2014
Lyme Disease Richard A. Jacobs, MD, PhD. NO DISCLOSURES Outline History of Lyme disease How the new disease was discovered How the etiology of the disease was discovered Clinical manifestations Diagnosis
More informationQ fever. Lyme disease LDA Conference Anja Garritsen 1. Lyme Disease Diagnostics. Today s presentation
Today s presentation Lyme Disease Diagnostics What can we use now What do we need for the future? Anja Garritsen, Innatoss Laboratories, NL Innatoss Diagnostics for Lyme Disease The present Diagnostic
More informationLyme Disease RHEUMATOLOGY BOARD REVIEW MANUAL. Table of Contents. Introduction Early Lyme Disease Lyme Arthritis... 7
RHEUMATOLOGY BOARD REVIEW MANUAL PUBLISHING STAFF PRESIDENT, PUBLISHER Bruce M. White EXECUTIVE EDITOR Debra Dreger SENIOR EDITOR Bobbie Lewis EDITOR Robert Litchkofski ASSISTANT EDITOR Melissa Frederick
More informationCase Classification West Nile Virus Neurological Syndrome (WNNS)
WEST NILE VIRUS Case definition Case Classification West Nile Virus Neurological Syndrome (WNNS) CONFIRMED CASE West Nile Virus Neurological Syndrome (WNNS) Clinical criteria AND at least one of the confirmed
More informationArea Laboratory Service
THIS IS A CONTROLLED DOCUMENT. DO NOT COPY Area Laboratory Service Organisational Unit: Title: Ref No: Version No: Date Issued: Author: Authorised by: Review date: Location of this Copy : Microbiology
More informationProspective Study of Serologic Tests for Lyme Disease
MAJOR ARTICLE Prospective Study of Serologic Tests for Lyme Disease Allen C. Steere, Gail McHugh, Nitin Damle, and Vijay K. Sikand Center for Immunology and Inflammatory Diseases, Division of Rheumatology,
More informationNO DISCLOSURES. Lyme Disease. Outline. Case 4/16/2014. Richard A. Jacobs, MD, PhD.
Lyme Disease Richard A. Jacobs, MD, PhD. NO DISCLOSURES Outline History of Lyme disease How the new disease was discovered How the etiology of the disease was discovered Clinical manifestations Diagnosis
More informationCouncil of State and Territorial Epidemiologists Position Statement
04-ID-01 Committee: Title: Infectious Disease Revision of the National Surveillance Case Definition of Diseases Caused by Neurotropic Domestic Arboviruses, Including the Addition to the NNDSS of Non-Neuroinvasive
More informationLyme Arthritis: A Comparison of Presentation, Synovial Fluid Analysis, and Treatment Course in Children and Adults
Arthritis Care & Research Vol. 65, No. 12, December 2013, pp 1986 1990 DOI 10.1002/acr.22086 2013, American College of Rheumatology ORIGINAL ARTICLE Lyme Arthritis: A Comparison of Presentation, Synovial
More informationThe New England Journal of Medicine LYME DISEASE IN CHILDREN IN SOUTHEASTERN CONNECTICUT. Study Population
LYME DISEASE IN CHILDREN IN SOUTHEASTERN CONNECTICUT MICHAEL A. GERBER, M.D., EUGENE D. SHAPIRO, M.D., GEORGINE S. BURKE, PH.D., VALERIE J. PARCELLS, R.N., AND GILLIAN L. BELL, B.L.T., FOR THE PEDIATRIC
More informationInsect bites (dengue, Chikungunya, Zika, Tick-Borne)
Insect bites (dengue, Chikungunya, Zika, Tick-Borne) Prof (Dr) Yee-Sin LEO Clinical Director Communicable Disease Centre Director Institute of Infectious Disease and Epidemiology Tan Tock Seng Hospital
More informationA Pharmacist's Guide to the Treatment of Lyme Disease
University of Wyoming Wyoming Scholars Repository Honors Theses AY 17/18 Undergraduate Honors Theses Spring 5-12-2018 A Pharmacist's Guide to the Treatment of Lyme Disease Karlee Miller kmille48@uwyo.edu
More informationCase Report Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome
Hindawi Case Reports in Infectious Diseases Volume 2017, Article ID 5847156, 4 pages https://doi.org/10.1155/2017/5847156 Case Report Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment
More informationClinician Approaches to the Diagnosis of the Patient with Suspected Lyme Disease
University of Connecticut DigitalCommons@UConn Master's Theses University of Connecticut Graduate School 5-5-2012 Clinician Approaches to the Diagnosis of the Patient with Suspected Lyme Disease Tyler
More informationLyme disease is a bacterial infection. Even if successfully treated, a person may become reinfected if bitten later by another infected tick.
Wappingers Central School District Lyme Disease & Tick Awareness Lyme Disease Updated: October 2011 What is Lyme disease? Lyme disease is caused by bacteria transmitted by the deer tick (Ixodes scapularis).
More informationAnnual Communicable Disease Report
Annual Communicable Disease Report 2017 Published March 12, 2018 Version 1 Prepared by: Public Health - Dayton & Montgomery County Planning & Preparedness Section Melissa A. Vining, BSN, RN Caren Stevens,
More informationResearch Article Proof That Chronic Lyme Disease Exists
Interdisciplinary Perspectives on Infectious Diseases Volume 2010, Article ID 876450, 4 pages doi:10.1155/2010/876450 Research Article Proof That Chronic Lyme Disease Exists Daniel J. Cameron Department
More informationLyme disease stakeholder scoping workshop
1.1 Who is the focus: Groups that will be covered: Adults and children with a suspected or confirmed diagnosis of Lyme disease 1.2. Settings All setting where NHS care The group suggested that the following
More informationLABORATORY TRENDS. Influenza Season Hits the Province BC PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC.
BC PUBLIC HEALTH In this Issue: Influenza Season Hits the Province The influenza season has started in North America with widespread activity in Canada, the majority of the United States and Mexico. In
More informationDavid Helfinstine Clinical Microbiology II July 31, Parvovirus B19
David Helfinstine Clinical Microbiology II July 31, 2007 Parvovirus B19 Parvovirus B19 Family: Parvoviridae Latin parvus means small ~20 nm in diameter (0.02 µm) Single-stranded DNA virus Icosahedral capsid
More informationOCCUPATIONAL HEALTH IMPLICATIONS: FROM LABORATORY TO FIELD
OCCUPATIONAL HEALTH IMPLICATIONS: FROM LABORATORY TO FIELD USDA ARS 5 TH INTERNATIONAL BIOSAFETY & BIOCONTAINMENT SYMPOSIUM February 13 th, 2019 Lee Wugofski MD,MPH Deputy Medical Director, CHS, FOH ASSESSING
More informationA Case of Optic Neuritis Secondary to Lyme Disease
CASE REPORT A Case of Optic Neuritis Secondary to Lyme Disease Pinky Jha, MD, MPH; Sophie G Rodrigues Pereira, BS; Abhishek Thakur, BS; Gurdeep Jhaj, MD; Sanjay Bhandari, MD ABSTRACT Introduction: Optic
More informationDo you think you have Lyme Disease? Fill out The Horowitz MSIDS Questionnaire (HMQ)
Do you think you have Lyme Disease? Fill out The Horowitz MSIDS Questionnaire (HMQ) Answer the following questions as honestly as possible. Think about how you have been feeling over the previous month
More informationEhrlichiosis/Anaplasmosis
Ehrlichiosis/Anaplasmosis Ehrlichia spp./anaplasma phagocytophilum DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by
More informationIssues in the Diagnosis and Treatment of Lyme Disease
Send Orders of Reprints at bspsaif@emirates.net.ae The Open Neurology Journal, 2012, 6, (Suppl 1-M8) 140-145 140 Issues in the Diagnosis and Treatment of Lyme Disease Open Access Sam T Donta* Department
More informationUsing administrative medical claims data to estimate underreporting of infectious zoonotic diseases
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 40% Percentage of Yearly Cases 30% 25% 20% 15% 10% 5% 0% January Februar March April May June July August Septem October Novem Decem January Februar March
More information11/9/2017 LLSA REVIEW 2017 ARTICLES 5-8. Human Trafficking. Defining Human Trafficking. Recognizing Human Trafficking in the ED
Human Trafficking LLSA REVIEW 2017 ARTICLES 5-8 Michael Gratson MD Recognizing Victims of Human Trafficking in the Pediatric Emergency Department. Becker HJ, Bechtel K. Pediatric Emerg Care 2015;31:144-150.
More informationANNUAL MORBIDITY REPORT
DUTCHESS COUNTY DEPARTMENT OF HEALTH S ANNUAL MORBIDITY REPORT Marcus J. Molinaro, Executive Kari Reiber, MD, Commissioner of Health Volume 9, Issue 1 85 Civic Center Plaza - Suite 106, Poughkeepsie, NY
More informationTicks and Tick Borne Diseases
Ticks & Lyme Disease Ticks and Tick Borne Diseases Bureau of Workers Compensation PA Training for Health & Safety (PATHS) 1 Topics Introduction to Problem Types Life Cycle Behavior Lyme Disease Signs &
More informationWHAT WE KNOW ABOUT ANAPLASMOSIS AND BORRELIOSIS AND WHAT WE DO NOT A. Rick Alleman, DVM, PhD, DACVP, DABVP
WHAT WE KNOW ABOUT ANAPLASMOSIS AND BORRELIOSIS AND WHAT WE DO NOT A. Rick Alleman, DVM, PhD, DACVP, DABVP Anaplasma phagocytophilum Anaplasma phagocytophilum is an intracellular, gram-negative bacterium
More informationLIMITING LYME DISEASE: USING SYSTEM DYNAMICS SIMULATION TO TARGET HEALTH INTERVENTIONS. Shilo Helen McBurney
LIMITING LYME DISEASE: USING SYSTEM DYNAMICS SIMULATION TO TARGET HEALTH INTERVENTIONS by Shilo Helen McBurney Submitted in partial fulfilment of the requirements for the degree of Master of Science at
More informationEVALUATION OF LYME DISEASE TESTS. I would like to thank Dr. Dumler for his reply to my letter expressing concerns regarding
Note: Andrew Onderdonk, editor of The Journal of Clinical Microbiology has refused to ask Dumler to dislose the results of his study or explain his erroneous arithmetic. Dumler has not provided results
More informationDisclosures. Ticked-off... Myths, Truths, and Realities of Tick-borne Infections including Lyme, Babesia, and Ehrlichia
Disclosures Ticked-off... Myths, Truths, and Realities of Tick-borne Infections including Lyme, Babesia, and Ehrlichia Vanessa Pomarico-Denino, MS, APRN, FNP-BC, FAANP Interim Director/Lead Faculty SCSU
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21004 holds various files of this Leiden University dissertation. Author: Burgel, Nathalie Daniëlle van Title: Host-pathogen interactions in Lyme disease
More informationClinical presentation of Lyme disease in the higher-risk region of Quebec: a retrospective descriptive study
Clinical presentation of Lyme disease in the higher-risk region of Quebec: a retrospective descriptive study OPEN Audrey Charbonneau MD, Louis-Philippe Charette MD, Geneviève Rouleau MD, Mélissa Savary
More informationT H E F A C T S T H E C H A L L E N G E
Lyme Disease THE FACTS THE CHALLENGE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases National Institute of Arthritis and
More informationMonthly Safety Meeting
Monthly Safety Meeting 26 June 2014 Please sign roster Before we begin Please sign the safety meeting roster Used to log safety currency in eservices Safety Officer logs currency Only other means (not
More informationNo Time for Lyme: Public Health Approaches to Lyme Disease in Vermont
University of Vermont ScholarWorks @ UVM UVM Honors College Senior Theses Undergraduate Theses 2015 No Time for Lyme: Public Health Approaches to Lyme Disease in Vermont Jessie Gay Follow this and additional
More information